{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:12:16Z","timestamp":1761894736400},"reference-count":20,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.leukres.2008.04.024","type":"journal-article","created":{"date-parts":[[2008,6,14]],"date-time":"2008-06-14T08:44:11Z","timestamp":1213433051000},"page":"1931-1935","source":"Crossref","is-referenced-by-count":42,"title":["Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm"],"prefix":"10.1016","volume":"32","author":[{"given":"Falko","family":"Fend","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Horn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ina","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Vela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attilio","family":"Orazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2008.04.024_bib1","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1365-2141.1994.tb06734.x","article-title":"The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia","volume":"87","author":"Bennett","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2008.04.024_bib2","series-title":"WHO classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues","first-page":"53","article-title":"Atypical chronic myeloid leukemia","author":"Vardiman","year":"2001"},{"key":"10.1016\/j.leukres.2008.04.024_bib3","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.04.024_bib4","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1200\/JCO.2001.19.11.2915","article-title":"BCR rearrangement-negative chronic myelogenous leukemia revisited","volume":"19","author":"Kurzrock","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2008.04.024_bib5","first-page":"1566","article-title":"Identification of risk factors in atypical chronic myeloid leukemia","volume":"91","author":"Breccia","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2008.04.024_bib6","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/cncr.10832","article-title":"Characteristics and outcome of patients with Philadelphia chromosome negative, bcr\/abl negative chronic myelogenous leukemia","volume":"95","author":"Onida","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2008.04.024_bib7","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood-2005-05-1800","article-title":"JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia","volume":"106","author":"Jelinek","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.04.024_bib8","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood-2005-03-1320","article-title":"Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders","volume":"106","author":"Jones","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.04.024_bib9","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1182\/blood-2005-05-1898","article-title":"The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia","volume":"106","author":"Levine","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.04.024_bib10","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood-2005-03-1183","article-title":"The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both \u201catypical\u201d myeloproliferative disorders and myelodysplastic syndromes","volume":"106","author":"Steensma","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.04.024_bib11","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1182\/blood-2006-02-005751","article-title":"Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation","volume":"108","author":"Szpurka","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.04.024_bib12","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/modpathol.3800707","article-title":"Chronic myelomonocytic leukemia: the role of bone marrow biopsy immunohistology","volume":"19","author":"Orazi","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.leukres.2008.04.024_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2353\/jmoldx.2006.050128","article-title":"Detection of the activating JAK2 V617F mutation in paraffin-embedded trephine bone marrow biopsies of patients with chronic myeloproliferative diseases","volume":"8","author":"Horn","year":"2006","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.leukres.2008.04.024_bib14","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.leukres.2008.04.024_bib15","unstructured":"Kremer M, Horn T, Koch I, Pfeifer WM, Tzankov A, Gattenl\u00f6hner S, et al. Quantitation of the JAK2 V617F mutation in microdissected bone marrow trephines: equal mutation load in myeloid lineages and rare involvement of lymphoid cells. Am J Surg Pathol; in press."},{"issue":"2","key":"10.1016\/j.leukres.2008.04.024_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000101709","article-title":"Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic\/myeloproliferative diseases","volume":"74","author":"Orazi","year":"2007","journal-title":"Pathobiology"},{"key":"10.1016\/j.leukres.2008.04.024_bib17","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1365-2141.2005.05719.x","article-title":"JAK2 V617F mutation is uncommon in chronic myelomonocytic leukaemia","volume":"130","author":"Johan","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2008.04.024_bib18","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/sj.leu.2404240","article-title":"Presence of JAK2 V617F tyrosine kinase mutation as a myeloid-lineage-specific mutation in chronic neutrophilic leukaemia","volume":"20","author":"Lea","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2008.04.024_bib19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/gcc.20014","article-title":"Molecular and cytogenetic characterization of a novel translocation t(4;22) involving the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with atypical chronic myeloid leukemia","volume":"40","author":"Safley","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.leukres.2008.04.024_bib20","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.leukres.2003.10.011","article-title":"A 2-year-old with atypical CML with a t(5;12)(q33;p13) treated successfully with imatinib mesylate","volume":"28","author":"Wittman","year":"2004","journal-title":"Leuk Res"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608002269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608002269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T03:37:37Z","timestamp":1557632257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212608002269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0145212608002269"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2008.04.024","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}